These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 36585968)

  • 21. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
    Cao J; Wu L; Zhang H
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.
    Yoshimura T; Sonoda KH; Sugahara M; Mochizuki Y; Enaida H; Oshima Y; Ueno A; Hata Y; Yoshida H; Ishibashi T
    PLoS One; 2009 Dec; 4(12):e8158. PubMed ID: 19997642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative ultrastructural analysis of the proliferative tissue in PDR patients with or without vitreous haemorrhage: from ultrastructural approach to clinical practice].
    Vidinova C; Vidinov N
    Klin Monbl Augenheilkd; 2007 Mar; 224(3):185-9. PubMed ID: 17385119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy.
    El-Asrar AM; Nawaz MI; Kangave D; Geboes K; Ola MS; Ahmad S; Al-Shabrawey M
    Mol Vis; 2011; 17():1829-38. PubMed ID: 21850157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlations between vitreous cytokine levels and inflammatory cells in fibrovascular membranes of patients with proliferative diabetic retinopathy.
    Urbančič M; Petrovič D; Živin AM; Korošec P; Fležar M; Petrovič MG
    Mol Vis; 2020; 26():472-482. PubMed ID: 32606566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-Dimensional Enhanced Imaging of Vitreoretinal Interface in Diabetic Retinopathy Using Swept-Source Optical Coherence Tomography.
    Adhi M; Badaro E; Liu JJ; Kraus MF; Baumal CR; Witkin AJ; Hornegger J; Fujimoto JG; Duker JS; Waheed NK
    Am J Ophthalmol; 2016 Feb; 162():140-149.e1. PubMed ID: 26548809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic insight into the pathogenesis of CAPN5-vitreoretinopathy.
    Velez G; Yang J; Li AS; Tsang SH; Bassuk AG; Mahajan VB
    Sci Rep; 2019 May; 9(1):7608. PubMed ID: 31110225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation.
    Snead DR; James S; Snead MP
    Eye (Lond); 2008 Oct; 22(10):1310-7. PubMed ID: 18344963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins.
    Kawahara S; Hata Y; Kita T; Arita R; Miura M; Nakao S; Mochizuki Y; Enaida H; Kagimoto T; Goto Y; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2008 Oct; 57(10):2784-93. PubMed ID: 18599521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.
    Kita T; Hata Y; Arita R; Kawahara S; Miura M; Nakao S; Mochizuki Y; Enaida H; Goto Y; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17504-9. PubMed ID: 18952846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The extracellular matrix of reparative tissue in the vitreous: fibronectin production in proliferative diabetic retinopathy membranes.
    Hiscott P; Waller HA; Grierson I; Butler MG; Scott DL
    Eye (Lond); 1993; 7 ( Pt 2)():288-92. PubMed ID: 7607348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative Proteomics Analysis of Vitreous Humor from Diabetic Retinopathy Patients.
    Loukovaara S; Nurkkala H; Tamene F; Gucciardo E; Liu X; Repo P; Lehti K; Varjosalo M
    J Proteome Res; 2015 Dec; 14(12):5131-43. PubMed ID: 26490944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy.
    Li J; Lu Q; Lu P
    BMC Ophthalmol; 2018 Jun; 18(1):151. PubMed ID: 29940965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of vitreous findings in diabetic retinopathy.
    Jalkh A; Takahashi M; Topilow HW; Trempe CL; McMeel JW
    Arch Ophthalmol; 1982 Mar; 100(3):432-4. PubMed ID: 7199900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of chemokines and growth factors in proliferative diabetic retinopathy vitreous.
    Dai Y; Wu Z; Wang F; Zhang Z; Yu M
    Biomed Res Int; 2014; 2014():486386. PubMed ID: 25401103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients.
    Kim T; Kim SJ; Kim K; Kang UB; Lee C; Park KS; Yu HG; Kim Y
    Proteomics; 2007 Nov; 7(22):4203-15. PubMed ID: 17955474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathogenesis of rhegmatogenous retinal detachment.
    Öhman T; Gawriyski L; Miettinen S; Varjosalo M; Loukovaara S
    Sci Rep; 2021 Jan; 11(1):966. PubMed ID: 33441730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Capeans C; De Rojas MV; Lojo S; Salorio MS
    Retina; 1998; 18(6):546-50. PubMed ID: 9869464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.